Global Sofosbuvir API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Sofosbuvir(CAS?1190307-88-0) is a medication used to treat hepatitis C.
LPI (LP Information)' newest research report, the “Sofosbuvir API Industry Forecast” looks at past sales and reviews total world Sofosbuvir API sales in 2022, providing a comprehensive analysis by region and market sector of projected Sofosbuvir API sales for 2023 through 2029. With Sofosbuvir API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sofosbuvir API industry.
This Insight Report provides a comprehensive analysis of the global Sofosbuvir API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sofosbuvir API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sofosbuvir API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sofosbuvir API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sofosbuvir API.
The global Sofosbuvir API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sofosbuvir API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sofosbuvir API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sofosbuvir API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sofosbuvir API players cover Mylan, Teva, Century Pharmaceuticals, Beijing Huikang Boyuan Chemical Tech Co.,Ltd, Fuxin Long Rui Pharmaceutical, Alembic Pharmaceuticals Limited, Hetero Drugs, Jiangsu Yutian Pharmaceutical and Aspire Lifesciences Pvt Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sofosbuvir API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Sofosbuvir API market?
What factors are driving Sofosbuvir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sofosbuvir API market opportunities vary by end market size?
How does Sofosbuvir API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Sofosbuvir(CAS?1190307-88-0) is a medication used to treat hepatitis C.
LPI (LP Information)' newest research report, the “Sofosbuvir API Industry Forecast” looks at past sales and reviews total world Sofosbuvir API sales in 2022, providing a comprehensive analysis by region and market sector of projected Sofosbuvir API sales for 2023 through 2029. With Sofosbuvir API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sofosbuvir API industry.
This Insight Report provides a comprehensive analysis of the global Sofosbuvir API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sofosbuvir API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sofosbuvir API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sofosbuvir API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sofosbuvir API.
The global Sofosbuvir API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sofosbuvir API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sofosbuvir API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sofosbuvir API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sofosbuvir API players cover Mylan, Teva, Century Pharmaceuticals, Beijing Huikang Boyuan Chemical Tech Co.,Ltd, Fuxin Long Rui Pharmaceutical, Alembic Pharmaceuticals Limited, Hetero Drugs, Jiangsu Yutian Pharmaceutical and Aspire Lifesciences Pvt Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sofosbuvir API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Above 98 %
- Above 99 %
- Tablets
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mylan
- Teva
- Century Pharmaceuticals
- Beijing Huikang Boyuan Chemical Tech Co.,Ltd
- Fuxin Long Rui Pharmaceutical
- Alembic Pharmaceuticals Limited
- Hetero Drugs
- Jiangsu Yutian Pharmaceutical
- Aspire Lifesciences Pvt Ltd
- Haoyuan Chemexpress Co.Ltd
- CHEMO
- Hanways Chempharm Co., Limited
- Guangzhou Tosun Pharmaceutical
- CAD Middle East Pharmaceutical Industries LLC
- Srini Pharmaceuticals
What is the 10-year outlook for the global Sofosbuvir API market?
What factors are driving Sofosbuvir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sofosbuvir API market opportunities vary by end market size?
How does Sofosbuvir API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sofosbuvir API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sofosbuvir API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sofosbuvir API by Country/Region, 2018, 2022 & 2029
2.2 Sofosbuvir API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Sofosbuvir API Sales by Type
2.3.1 Global Sofosbuvir API Sales Market Share by Type (2018-2023)
2.3.2 Global Sofosbuvir API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sofosbuvir API Sale Price by Type (2018-2023)
2.4 Sofosbuvir API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Sofosbuvir API Sales by Application
2.5.1 Global Sofosbuvir API Sale Market Share by Application (2018-2023)
2.5.2 Global Sofosbuvir API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sofosbuvir API Sale Price by Application (2018-2023)
3 GLOBAL SOFOSBUVIR API BY COMPANY
3.1 Global Sofosbuvir API Breakdown Data by Company
3.1.1 Global Sofosbuvir API Annual Sales by Company (2018-2023)
3.1.2 Global Sofosbuvir API Sales Market Share by Company (2018-2023)
3.2 Global Sofosbuvir API Annual Revenue by Company (2018-2023)
3.2.1 Global Sofosbuvir API Revenue by Company (2018-2023)
3.2.2 Global Sofosbuvir API Revenue Market Share by Company (2018-2023)
3.3 Global Sofosbuvir API Sale Price by Company
3.4 Key Manufacturers Sofosbuvir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sofosbuvir API Product Location Distribution
3.4.2 Players Sofosbuvir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SOFOSBUVIR API BY GEOGRAPHIC REGION
4.1 World Historic Sofosbuvir API Market Size by Geographic Region (2018-2023)
4.1.1 Global Sofosbuvir API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sofosbuvir API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sofosbuvir API Market Size by Country/Region (2018-2023)
4.2.1 Global Sofosbuvir API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sofosbuvir API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sofosbuvir API Sales Growth
4.4 APAC Sofosbuvir API Sales Growth
4.5 Europe Sofosbuvir API Sales Growth
4.6 Middle East & Africa Sofosbuvir API Sales Growth
5 AMERICAS
5.1 Americas Sofosbuvir API Sales by Country
5.1.1 Americas Sofosbuvir API Sales by Country (2018-2023)
5.1.2 Americas Sofosbuvir API Revenue by Country (2018-2023)
5.2 Americas Sofosbuvir API Sales by Type
5.3 Americas Sofosbuvir API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sofosbuvir API Sales by Region
6.1.1 APAC Sofosbuvir API Sales by Region (2018-2023)
6.1.2 APAC Sofosbuvir API Revenue by Region (2018-2023)
6.2 APAC Sofosbuvir API Sales by Type
6.3 APAC Sofosbuvir API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sofosbuvir API by Country
7.1.1 Europe Sofosbuvir API Sales by Country (2018-2023)
7.1.2 Europe Sofosbuvir API Revenue by Country (2018-2023)
7.2 Europe Sofosbuvir API Sales by Type
7.3 Europe Sofosbuvir API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sofosbuvir API by Country
8.1.1 Middle East & Africa Sofosbuvir API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sofosbuvir API Revenue by Country (2018-2023)
8.2 Middle East & Africa Sofosbuvir API Sales by Type
8.3 Middle East & Africa Sofosbuvir API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sofosbuvir API
10.3 Manufacturing Process Analysis of Sofosbuvir API
10.4 Industry Chain Structure of Sofosbuvir API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sofosbuvir API Distributors
11.3 Sofosbuvir API Customer
12 WORLD FORECAST REVIEW FOR SOFOSBUVIR API BY GEOGRAPHIC REGION
12.1 Global Sofosbuvir API Market Size Forecast by Region
12.1.1 Global Sofosbuvir API Forecast by Region (2024-2029)
12.1.2 Global Sofosbuvir API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sofosbuvir API Forecast by Type
12.7 Global Sofosbuvir API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Mylan
13.1.1 Mylan Company Information
13.1.2 Mylan Sofosbuvir API Product Portfolios and Specifications
13.1.3 Mylan Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Mylan Main Business Overview
13.1.5 Mylan Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Sofosbuvir API Product Portfolios and Specifications
13.2.3 Teva Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Century Pharmaceuticals
13.3.1 Century Pharmaceuticals Company Information
13.3.2 Century Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
13.3.3 Century Pharmaceuticals Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Century Pharmaceuticals Main Business Overview
13.3.5 Century Pharmaceuticals Latest Developments
13.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd
13.4.1 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Company Information
13.4.2 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Portfolios and Specifications
13.4.3 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Main Business Overview
13.4.5 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Latest Developments
13.5 Fuxin Long Rui Pharmaceutical
13.5.1 Fuxin Long Rui Pharmaceutical Company Information
13.5.2 Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
13.5.3 Fuxin Long Rui Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Fuxin Long Rui Pharmaceutical Main Business Overview
13.5.5 Fuxin Long Rui Pharmaceutical Latest Developments
13.6 Alembic Pharmaceuticals Limited
13.6.1 Alembic Pharmaceuticals Limited Company Information
13.6.2 Alembic Pharmaceuticals Limited Sofosbuvir API Product Portfolios and Specifications
13.6.3 Alembic Pharmaceuticals Limited Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alembic Pharmaceuticals Limited Main Business Overview
13.6.5 Alembic Pharmaceuticals Limited Latest Developments
13.7 Hetero Drugs
13.7.1 Hetero Drugs Company Information
13.7.2 Hetero Drugs Sofosbuvir API Product Portfolios and Specifications
13.7.3 Hetero Drugs Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Drugs Main Business Overview
13.7.5 Hetero Drugs Latest Developments
13.8 Jiangsu Yutian Pharmaceutical
13.8.1 Jiangsu Yutian Pharmaceutical Company Information
13.8.2 Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
13.8.3 Jiangsu Yutian Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiangsu Yutian Pharmaceutical Main Business Overview
13.8.5 Jiangsu Yutian Pharmaceutical Latest Developments
13.9 Aspire Lifesciences Pvt Ltd
13.9.1 Aspire Lifesciences Pvt Ltd Company Information
13.9.2 Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Portfolios and Specifications
13.9.3 Aspire Lifesciences Pvt Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aspire Lifesciences Pvt Ltd Main Business Overview
13.9.5 Aspire Lifesciences Pvt Ltd Latest Developments
13.10 Haoyuan Chemexpress Co.Ltd
13.10.1 Haoyuan Chemexpress Co.Ltd Company Information
13.10.2 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Portfolios and Specifications
13.10.3 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Haoyuan Chemexpress Co.Ltd Main Business Overview
13.10.5 Haoyuan Chemexpress Co.Ltd Latest Developments
13.11 CHEMO
13.11.1 CHEMO Company Information
13.11.2 CHEMO Sofosbuvir API Product Portfolios and Specifications
13.11.3 CHEMO Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CHEMO Main Business Overview
13.11.5 CHEMO Latest Developments
13.12 Hanways Chempharm Co., Limited
13.12.1 Hanways Chempharm Co., Limited Company Information
13.12.2 Hanways Chempharm Co., Limited Sofosbuvir API Product Portfolios and Specifications
13.12.3 Hanways Chempharm Co., Limited Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hanways Chempharm Co., Limited Main Business Overview
13.12.5 Hanways Chempharm Co., Limited Latest Developments
13.13 Guangzhou Tosun Pharmaceutical
13.13.1 Guangzhou Tosun Pharmaceutical Company Information
13.13.2 Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
13.13.3 Guangzhou Tosun Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangzhou Tosun Pharmaceutical Main Business Overview
13.13.5 Guangzhou Tosun Pharmaceutical Latest Developments
13.14 CAD Middle East Pharmaceutical Industries LLC
13.14.1 CAD Middle East Pharmaceutical Industries LLC Company Information
13.14.2 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Portfolios and Specifications
13.14.3 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CAD Middle East Pharmaceutical Industries LLC Main Business Overview
13.14.5 CAD Middle East Pharmaceutical Industries LLC Latest Developments
13.15 Srini Pharmaceuticals
13.15.1 Srini Pharmaceuticals Company Information
13.15.2 Srini Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
13.15.3 Srini Pharmaceuticals Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Srini Pharmaceuticals Main Business Overview
13.15.5 Srini Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sofosbuvir API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sofosbuvir API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sofosbuvir API by Country/Region, 2018, 2022 & 2029
2.2 Sofosbuvir API Segment by Type
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Sofosbuvir API Sales by Type
2.3.1 Global Sofosbuvir API Sales Market Share by Type (2018-2023)
2.3.2 Global Sofosbuvir API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sofosbuvir API Sale Price by Type (2018-2023)
2.4 Sofosbuvir API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Sofosbuvir API Sales by Application
2.5.1 Global Sofosbuvir API Sale Market Share by Application (2018-2023)
2.5.2 Global Sofosbuvir API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sofosbuvir API Sale Price by Application (2018-2023)
3 GLOBAL SOFOSBUVIR API BY COMPANY
3.1 Global Sofosbuvir API Breakdown Data by Company
3.1.1 Global Sofosbuvir API Annual Sales by Company (2018-2023)
3.1.2 Global Sofosbuvir API Sales Market Share by Company (2018-2023)
3.2 Global Sofosbuvir API Annual Revenue by Company (2018-2023)
3.2.1 Global Sofosbuvir API Revenue by Company (2018-2023)
3.2.2 Global Sofosbuvir API Revenue Market Share by Company (2018-2023)
3.3 Global Sofosbuvir API Sale Price by Company
3.4 Key Manufacturers Sofosbuvir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sofosbuvir API Product Location Distribution
3.4.2 Players Sofosbuvir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SOFOSBUVIR API BY GEOGRAPHIC REGION
4.1 World Historic Sofosbuvir API Market Size by Geographic Region (2018-2023)
4.1.1 Global Sofosbuvir API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sofosbuvir API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sofosbuvir API Market Size by Country/Region (2018-2023)
4.2.1 Global Sofosbuvir API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sofosbuvir API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sofosbuvir API Sales Growth
4.4 APAC Sofosbuvir API Sales Growth
4.5 Europe Sofosbuvir API Sales Growth
4.6 Middle East & Africa Sofosbuvir API Sales Growth
5 AMERICAS
5.1 Americas Sofosbuvir API Sales by Country
5.1.1 Americas Sofosbuvir API Sales by Country (2018-2023)
5.1.2 Americas Sofosbuvir API Revenue by Country (2018-2023)
5.2 Americas Sofosbuvir API Sales by Type
5.3 Americas Sofosbuvir API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sofosbuvir API Sales by Region
6.1.1 APAC Sofosbuvir API Sales by Region (2018-2023)
6.1.2 APAC Sofosbuvir API Revenue by Region (2018-2023)
6.2 APAC Sofosbuvir API Sales by Type
6.3 APAC Sofosbuvir API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sofosbuvir API by Country
7.1.1 Europe Sofosbuvir API Sales by Country (2018-2023)
7.1.2 Europe Sofosbuvir API Revenue by Country (2018-2023)
7.2 Europe Sofosbuvir API Sales by Type
7.3 Europe Sofosbuvir API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sofosbuvir API by Country
8.1.1 Middle East & Africa Sofosbuvir API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sofosbuvir API Revenue by Country (2018-2023)
8.2 Middle East & Africa Sofosbuvir API Sales by Type
8.3 Middle East & Africa Sofosbuvir API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sofosbuvir API
10.3 Manufacturing Process Analysis of Sofosbuvir API
10.4 Industry Chain Structure of Sofosbuvir API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sofosbuvir API Distributors
11.3 Sofosbuvir API Customer
12 WORLD FORECAST REVIEW FOR SOFOSBUVIR API BY GEOGRAPHIC REGION
12.1 Global Sofosbuvir API Market Size Forecast by Region
12.1.1 Global Sofosbuvir API Forecast by Region (2024-2029)
12.1.2 Global Sofosbuvir API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sofosbuvir API Forecast by Type
12.7 Global Sofosbuvir API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Mylan
13.1.1 Mylan Company Information
13.1.2 Mylan Sofosbuvir API Product Portfolios and Specifications
13.1.3 Mylan Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Mylan Main Business Overview
13.1.5 Mylan Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Sofosbuvir API Product Portfolios and Specifications
13.2.3 Teva Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Century Pharmaceuticals
13.3.1 Century Pharmaceuticals Company Information
13.3.2 Century Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
13.3.3 Century Pharmaceuticals Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Century Pharmaceuticals Main Business Overview
13.3.5 Century Pharmaceuticals Latest Developments
13.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd
13.4.1 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Company Information
13.4.2 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Portfolios and Specifications
13.4.3 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Main Business Overview
13.4.5 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Latest Developments
13.5 Fuxin Long Rui Pharmaceutical
13.5.1 Fuxin Long Rui Pharmaceutical Company Information
13.5.2 Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
13.5.3 Fuxin Long Rui Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Fuxin Long Rui Pharmaceutical Main Business Overview
13.5.5 Fuxin Long Rui Pharmaceutical Latest Developments
13.6 Alembic Pharmaceuticals Limited
13.6.1 Alembic Pharmaceuticals Limited Company Information
13.6.2 Alembic Pharmaceuticals Limited Sofosbuvir API Product Portfolios and Specifications
13.6.3 Alembic Pharmaceuticals Limited Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alembic Pharmaceuticals Limited Main Business Overview
13.6.5 Alembic Pharmaceuticals Limited Latest Developments
13.7 Hetero Drugs
13.7.1 Hetero Drugs Company Information
13.7.2 Hetero Drugs Sofosbuvir API Product Portfolios and Specifications
13.7.3 Hetero Drugs Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Drugs Main Business Overview
13.7.5 Hetero Drugs Latest Developments
13.8 Jiangsu Yutian Pharmaceutical
13.8.1 Jiangsu Yutian Pharmaceutical Company Information
13.8.2 Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
13.8.3 Jiangsu Yutian Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiangsu Yutian Pharmaceutical Main Business Overview
13.8.5 Jiangsu Yutian Pharmaceutical Latest Developments
13.9 Aspire Lifesciences Pvt Ltd
13.9.1 Aspire Lifesciences Pvt Ltd Company Information
13.9.2 Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Portfolios and Specifications
13.9.3 Aspire Lifesciences Pvt Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Aspire Lifesciences Pvt Ltd Main Business Overview
13.9.5 Aspire Lifesciences Pvt Ltd Latest Developments
13.10 Haoyuan Chemexpress Co.Ltd
13.10.1 Haoyuan Chemexpress Co.Ltd Company Information
13.10.2 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Portfolios and Specifications
13.10.3 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Haoyuan Chemexpress Co.Ltd Main Business Overview
13.10.5 Haoyuan Chemexpress Co.Ltd Latest Developments
13.11 CHEMO
13.11.1 CHEMO Company Information
13.11.2 CHEMO Sofosbuvir API Product Portfolios and Specifications
13.11.3 CHEMO Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CHEMO Main Business Overview
13.11.5 CHEMO Latest Developments
13.12 Hanways Chempharm Co., Limited
13.12.1 Hanways Chempharm Co., Limited Company Information
13.12.2 Hanways Chempharm Co., Limited Sofosbuvir API Product Portfolios and Specifications
13.12.3 Hanways Chempharm Co., Limited Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hanways Chempharm Co., Limited Main Business Overview
13.12.5 Hanways Chempharm Co., Limited Latest Developments
13.13 Guangzhou Tosun Pharmaceutical
13.13.1 Guangzhou Tosun Pharmaceutical Company Information
13.13.2 Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
13.13.3 Guangzhou Tosun Pharmaceutical Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangzhou Tosun Pharmaceutical Main Business Overview
13.13.5 Guangzhou Tosun Pharmaceutical Latest Developments
13.14 CAD Middle East Pharmaceutical Industries LLC
13.14.1 CAD Middle East Pharmaceutical Industries LLC Company Information
13.14.2 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Portfolios and Specifications
13.14.3 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CAD Middle East Pharmaceutical Industries LLC Main Business Overview
13.14.5 CAD Middle East Pharmaceutical Industries LLC Latest Developments
13.15 Srini Pharmaceuticals
13.15.1 Srini Pharmaceuticals Company Information
13.15.2 Srini Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
13.15.3 Srini Pharmaceuticals Sofosbuvir API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Srini Pharmaceuticals Main Business Overview
13.15.5 Srini Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sofosbuvir API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sofosbuvir API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 6. Global Sofosbuvir API Sales Market Share by Type (2018-2023)
Table 7. Global Sofosbuvir API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sofosbuvir API Revenue Market Share by Type (2018-2023)
Table 9. Global Sofosbuvir API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 11. Global Sofosbuvir API Sales Market Share by Application (2018-2023)
Table 12. Global Sofosbuvir API Revenue by Application (2018-2023)
Table 13. Global Sofosbuvir API Revenue Market Share by Application (2018-2023)
Table 14. Global Sofosbuvir API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Sofosbuvir API Sales by Company (2018-2023) & (Kg)
Table 16. Global Sofosbuvir API Sales Market Share by Company (2018-2023)
Table 17. Global Sofosbuvir API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sofosbuvir API Revenue Market Share by Company (2018-2023)
Table 19. Global Sofosbuvir API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Sofosbuvir API Producing Area Distribution and Sales Area
Table 21. Players Sofosbuvir API Products Offered
Table 22. Sofosbuvir API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sofosbuvir API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Sofosbuvir API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sofosbuvir API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sofosbuvir API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sofosbuvir API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Sofosbuvir API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sofosbuvir API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sofosbuvir API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sofosbuvir API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Sofosbuvir API Sales Market Share by Country (2018-2023)
Table 35. Americas Sofosbuvir API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sofosbuvir API Revenue Market Share by Country (2018-2023)
Table 37. Americas Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Sofosbuvir API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Sofosbuvir API Sales Market Share by Region (2018-2023)
Table 41. APAC Sofosbuvir API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sofosbuvir API Revenue Market Share by Region (2018-2023)
Table 43. APAC Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Sofosbuvir API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Sofosbuvir API Sales Market Share by Country (2018-2023)
Table 47. Europe Sofosbuvir API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sofosbuvir API Revenue Market Share by Country (2018-2023)
Table 49. Europe Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Sofosbuvir API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Sofosbuvir API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sofosbuvir API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sofosbuvir API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Sofosbuvir API
Table 58. Key Market Challenges & Risks of Sofosbuvir API
Table 59. Key Industry Trends of Sofosbuvir API
Table 60. Sofosbuvir API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sofosbuvir API Distributors List
Table 63. Sofosbuvir API Customer List
Table 64. Global Sofosbuvir API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Sofosbuvir API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sofosbuvir API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Sofosbuvir API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sofosbuvir API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Sofosbuvir API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sofosbuvir API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Sofosbuvir API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sofosbuvir API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Sofosbuvir API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sofosbuvir API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Sofosbuvir API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sofosbuvir API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Sofosbuvir API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Mylan Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Sofosbuvir API Product Portfolios and Specifications
Table 80. Mylan Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Teva Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Sofosbuvir API Product Portfolios and Specifications
Table 85. Teva Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Century Pharmaceuticals Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 89. Century Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
Table 90. Century Pharmaceuticals Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Century Pharmaceuticals Main Business
Table 92. Century Pharmaceuticals Latest Developments
Table 93. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 94. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Portfolios and Specifications
Table 95. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Main Business
Table 97. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Latest Developments
Table 98. Fuxin Long Rui Pharmaceutical Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 99. Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
Table 100. Fuxin Long Rui Pharmaceutical Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Fuxin Long Rui Pharmaceutical Main Business
Table 102. Fuxin Long Rui Pharmaceutical Latest Developments
Table 103. Alembic Pharmaceuticals Limited Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 104. Alembic Pharmaceuticals Limited Sofosbuvir API Product Portfolios and Specifications
Table 105. Alembic Pharmaceuticals Limited Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Alembic Pharmaceuticals Limited Main Business
Table 107. Alembic Pharmaceuticals Limited Latest Developments
Table 108. Hetero Drugs Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 109. Hetero Drugs Sofosbuvir API Product Portfolios and Specifications
Table 110. Hetero Drugs Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Hetero Drugs Main Business
Table 112. Hetero Drugs Latest Developments
Table 113. Jiangsu Yutian Pharmaceutical Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
Table 115. Jiangsu Yutian Pharmaceutical Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Jiangsu Yutian Pharmaceutical Main Business
Table 117. Jiangsu Yutian Pharmaceutical Latest Developments
Table 118. Aspire Lifesciences Pvt Ltd Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Portfolios and Specifications
Table 120. Aspire Lifesciences Pvt Ltd Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Aspire Lifesciences Pvt Ltd Main Business
Table 122. Aspire Lifesciences Pvt Ltd Latest Developments
Table 123. Haoyuan Chemexpress Co.Ltd Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 124. Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Portfolios and Specifications
Table 125. Haoyuan Chemexpress Co.Ltd Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Haoyuan Chemexpress Co.Ltd Main Business
Table 127. Haoyuan Chemexpress Co.Ltd Latest Developments
Table 128. CHEMO Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 129. CHEMO Sofosbuvir API Product Portfolios and Specifications
Table 130. CHEMO Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. CHEMO Main Business
Table 132. CHEMO Latest Developments
Table 133. Hanways Chempharm Co., Limited Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hanways Chempharm Co., Limited Sofosbuvir API Product Portfolios and Specifications
Table 135. Hanways Chempharm Co., Limited Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Hanways Chempharm Co., Limited Main Business
Table 137. Hanways Chempharm Co., Limited Latest Developments
Table 138. Guangzhou Tosun Pharmaceutical Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 139. Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
Table 140. Guangzhou Tosun Pharmaceutical Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Guangzhou Tosun Pharmaceutical Main Business
Table 142. Guangzhou Tosun Pharmaceutical Latest Developments
Table 143. CAD Middle East Pharmaceutical Industries LLC Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 144. CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Portfolios and Specifications
Table 145. CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 146. CAD Middle East Pharmaceutical Industries LLC Main Business
Table 147. CAD Middle East Pharmaceutical Industries LLC Latest Developments
Table 148. Srini Pharmaceuticals Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 149. Srini Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
Table 150. Srini Pharmaceuticals Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 151. Srini Pharmaceuticals Main Business
Table 152. Srini Pharmaceuticals Latest Developments
Table 1. Sofosbuvir API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sofosbuvir API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 6. Global Sofosbuvir API Sales Market Share by Type (2018-2023)
Table 7. Global Sofosbuvir API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sofosbuvir API Revenue Market Share by Type (2018-2023)
Table 9. Global Sofosbuvir API Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 11. Global Sofosbuvir API Sales Market Share by Application (2018-2023)
Table 12. Global Sofosbuvir API Revenue by Application (2018-2023)
Table 13. Global Sofosbuvir API Revenue Market Share by Application (2018-2023)
Table 14. Global Sofosbuvir API Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Sofosbuvir API Sales by Company (2018-2023) & (Kg)
Table 16. Global Sofosbuvir API Sales Market Share by Company (2018-2023)
Table 17. Global Sofosbuvir API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sofosbuvir API Revenue Market Share by Company (2018-2023)
Table 19. Global Sofosbuvir API Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Sofosbuvir API Producing Area Distribution and Sales Area
Table 21. Players Sofosbuvir API Products Offered
Table 22. Sofosbuvir API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sofosbuvir API Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Sofosbuvir API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sofosbuvir API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sofosbuvir API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sofosbuvir API Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Sofosbuvir API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sofosbuvir API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sofosbuvir API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sofosbuvir API Sales by Country (2018-2023) & (Kg)
Table 34. Americas Sofosbuvir API Sales Market Share by Country (2018-2023)
Table 35. Americas Sofosbuvir API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sofosbuvir API Revenue Market Share by Country (2018-2023)
Table 37. Americas Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 38. Americas Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 39. APAC Sofosbuvir API Sales by Region (2018-2023) & (Kg)
Table 40. APAC Sofosbuvir API Sales Market Share by Region (2018-2023)
Table 41. APAC Sofosbuvir API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sofosbuvir API Revenue Market Share by Region (2018-2023)
Table 43. APAC Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 44. APAC Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 45. Europe Sofosbuvir API Sales by Country (2018-2023) & (Kg)
Table 46. Europe Sofosbuvir API Sales Market Share by Country (2018-2023)
Table 47. Europe Sofosbuvir API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sofosbuvir API Revenue Market Share by Country (2018-2023)
Table 49. Europe Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 50. Europe Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Sofosbuvir API Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Sofosbuvir API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sofosbuvir API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sofosbuvir API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sofosbuvir API Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Sofosbuvir API Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Sofosbuvir API
Table 58. Key Market Challenges & Risks of Sofosbuvir API
Table 59. Key Industry Trends of Sofosbuvir API
Table 60. Sofosbuvir API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sofosbuvir API Distributors List
Table 63. Sofosbuvir API Customer List
Table 64. Global Sofosbuvir API Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Sofosbuvir API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sofosbuvir API Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Sofosbuvir API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sofosbuvir API Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Sofosbuvir API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sofosbuvir API Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Sofosbuvir API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sofosbuvir API Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Sofosbuvir API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sofosbuvir API Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Sofosbuvir API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sofosbuvir API Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Sofosbuvir API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Mylan Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Sofosbuvir API Product Portfolios and Specifications
Table 80. Mylan Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Teva Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Sofosbuvir API Product Portfolios and Specifications
Table 85. Teva Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Century Pharmaceuticals Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 89. Century Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
Table 90. Century Pharmaceuticals Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Century Pharmaceuticals Main Business
Table 92. Century Pharmaceuticals Latest Developments
Table 93. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 94. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Portfolios and Specifications
Table 95. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Main Business
Table 97. Beijing Huikang Boyuan Chemical Tech Co.,Ltd Latest Developments
Table 98. Fuxin Long Rui Pharmaceutical Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 99. Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
Table 100. Fuxin Long Rui Pharmaceutical Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Fuxin Long Rui Pharmaceutical Main Business
Table 102. Fuxin Long Rui Pharmaceutical Latest Developments
Table 103. Alembic Pharmaceuticals Limited Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 104. Alembic Pharmaceuticals Limited Sofosbuvir API Product Portfolios and Specifications
Table 105. Alembic Pharmaceuticals Limited Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Alembic Pharmaceuticals Limited Main Business
Table 107. Alembic Pharmaceuticals Limited Latest Developments
Table 108. Hetero Drugs Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 109. Hetero Drugs Sofosbuvir API Product Portfolios and Specifications
Table 110. Hetero Drugs Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Hetero Drugs Main Business
Table 112. Hetero Drugs Latest Developments
Table 113. Jiangsu Yutian Pharmaceutical Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
Table 115. Jiangsu Yutian Pharmaceutical Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Jiangsu Yutian Pharmaceutical Main Business
Table 117. Jiangsu Yutian Pharmaceutical Latest Developments
Table 118. Aspire Lifesciences Pvt Ltd Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 119. Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Portfolios and Specifications
Table 120. Aspire Lifesciences Pvt Ltd Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Aspire Lifesciences Pvt Ltd Main Business
Table 122. Aspire Lifesciences Pvt Ltd Latest Developments
Table 123. Haoyuan Chemexpress Co.Ltd Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 124. Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Portfolios and Specifications
Table 125. Haoyuan Chemexpress Co.Ltd Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Haoyuan Chemexpress Co.Ltd Main Business
Table 127. Haoyuan Chemexpress Co.Ltd Latest Developments
Table 128. CHEMO Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 129. CHEMO Sofosbuvir API Product Portfolios and Specifications
Table 130. CHEMO Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. CHEMO Main Business
Table 132. CHEMO Latest Developments
Table 133. Hanways Chempharm Co., Limited Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hanways Chempharm Co., Limited Sofosbuvir API Product Portfolios and Specifications
Table 135. Hanways Chempharm Co., Limited Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Hanways Chempharm Co., Limited Main Business
Table 137. Hanways Chempharm Co., Limited Latest Developments
Table 138. Guangzhou Tosun Pharmaceutical Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 139. Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Portfolios and Specifications
Table 140. Guangzhou Tosun Pharmaceutical Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Guangzhou Tosun Pharmaceutical Main Business
Table 142. Guangzhou Tosun Pharmaceutical Latest Developments
Table 143. CAD Middle East Pharmaceutical Industries LLC Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 144. CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Portfolios and Specifications
Table 145. CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 146. CAD Middle East Pharmaceutical Industries LLC Main Business
Table 147. CAD Middle East Pharmaceutical Industries LLC Latest Developments
Table 148. Srini Pharmaceuticals Basic Information, Sofosbuvir API Manufacturing Base, Sales Area and Its Competitors
Table 149. Srini Pharmaceuticals Sofosbuvir API Product Portfolios and Specifications
Table 150. Srini Pharmaceuticals Sofosbuvir API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 151. Srini Pharmaceuticals Main Business
Table 152. Srini Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sofosbuvir API
Figure 2. Sofosbuvir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sofosbuvir API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Sofosbuvir API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sofosbuvir API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Sofosbuvir API Sales Market Share by Type in 2022
Figure 12. Global Sofosbuvir API Revenue Market Share by Type (2018-2023)
Figure 13. Sofosbuvir API Consumed in Tablets
Figure 14. Global Sofosbuvir API Market: Tablets (2018-2023) & (Kg)
Figure 15. Sofosbuvir API Consumed in Others
Figure 16. Global Sofosbuvir API Market: Others (2018-2023) & (Kg)
Figure 17. Global Sofosbuvir API Sales Market Share by Application (2022)
Figure 18. Global Sofosbuvir API Revenue Market Share by Application in 2022
Figure 19. Sofosbuvir API Sales Market by Company in 2022 (Kg)
Figure 20. Global Sofosbuvir API Sales Market Share by Company in 2022
Figure 21. Sofosbuvir API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Sofosbuvir API Revenue Market Share by Company in 2022
Figure 23. Global Sofosbuvir API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Sofosbuvir API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Sofosbuvir API Sales 2018-2023 (Kg)
Figure 26. Americas Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Sofosbuvir API Sales 2018-2023 (Kg)
Figure 28. APAC Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Sofosbuvir API Sales 2018-2023 (Kg)
Figure 30. Europe Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Sofosbuvir API Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Sofosbuvir API Sales Market Share by Country in 2022
Figure 34. Americas Sofosbuvir API Revenue Market Share by Country in 2022
Figure 35. Americas Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 36. Americas Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 37. United States Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Sofosbuvir API Sales Market Share by Region in 2022
Figure 42. APAC Sofosbuvir API Revenue Market Share by Regions in 2022
Figure 43. APAC Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 44. APAC Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 45. China Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Sofosbuvir API Sales Market Share by Country in 2022
Figure 53. Europe Sofosbuvir API Revenue Market Share by Country in 2022
Figure 54. Europe Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 55. Europe Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 56. Germany Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Sofosbuvir API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Sofosbuvir API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Sofosbuvir API in 2022
Figure 71. Manufacturing Process Analysis of Sofosbuvir API
Figure 72. Industry Chain Structure of Sofosbuvir API
Figure 73. Channels of Distribution
Figure 74. Global Sofosbuvir API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Sofosbuvir API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Sofosbuvir API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Sofosbuvir API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Sofosbuvir API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Sofosbuvir API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Sofosbuvir API
Figure 2. Sofosbuvir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sofosbuvir API Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Sofosbuvir API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sofosbuvir API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Sofosbuvir API Sales Market Share by Type in 2022
Figure 12. Global Sofosbuvir API Revenue Market Share by Type (2018-2023)
Figure 13. Sofosbuvir API Consumed in Tablets
Figure 14. Global Sofosbuvir API Market: Tablets (2018-2023) & (Kg)
Figure 15. Sofosbuvir API Consumed in Others
Figure 16. Global Sofosbuvir API Market: Others (2018-2023) & (Kg)
Figure 17. Global Sofosbuvir API Sales Market Share by Application (2022)
Figure 18. Global Sofosbuvir API Revenue Market Share by Application in 2022
Figure 19. Sofosbuvir API Sales Market by Company in 2022 (Kg)
Figure 20. Global Sofosbuvir API Sales Market Share by Company in 2022
Figure 21. Sofosbuvir API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Sofosbuvir API Revenue Market Share by Company in 2022
Figure 23. Global Sofosbuvir API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Sofosbuvir API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Sofosbuvir API Sales 2018-2023 (Kg)
Figure 26. Americas Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Sofosbuvir API Sales 2018-2023 (Kg)
Figure 28. APAC Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Sofosbuvir API Sales 2018-2023 (Kg)
Figure 30. Europe Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Sofosbuvir API Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Sofosbuvir API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Sofosbuvir API Sales Market Share by Country in 2022
Figure 34. Americas Sofosbuvir API Revenue Market Share by Country in 2022
Figure 35. Americas Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 36. Americas Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 37. United States Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Sofosbuvir API Sales Market Share by Region in 2022
Figure 42. APAC Sofosbuvir API Revenue Market Share by Regions in 2022
Figure 43. APAC Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 44. APAC Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 45. China Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Sofosbuvir API Sales Market Share by Country in 2022
Figure 53. Europe Sofosbuvir API Revenue Market Share by Country in 2022
Figure 54. Europe Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 55. Europe Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 56. Germany Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Sofosbuvir API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Sofosbuvir API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Sofosbuvir API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Sofosbuvir API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Sofosbuvir API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Sofosbuvir API in 2022
Figure 71. Manufacturing Process Analysis of Sofosbuvir API
Figure 72. Industry Chain Structure of Sofosbuvir API
Figure 73. Channels of Distribution
Figure 74. Global Sofosbuvir API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Sofosbuvir API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Sofosbuvir API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Sofosbuvir API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Sofosbuvir API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Sofosbuvir API Revenue Market Share Forecast by Application (2024-2029)
